Cargando…

Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients

Detalles Bibliográficos
Autores principales:	Schuelke, Matthew R., Bassiri, Hamid, Behrens, Edward M., Canna, Scott, Croy, Colleen, DiNofia, Amanda, Gollomp, Kandace, Grupp, Stephan, Lambert, Michele, Lambrix, Arathi, Maude, Shannon L., Myers, Regina, Newman, Haley, Petrosa, Whitney, Seif, Alix, Sullivan, Kathleen E., Teachey, David T., Diorio, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514204/ https://www.ncbi.nlm.nih.gov/pubmed/37721859 http://dx.doi.org/10.1182/bloodadvances.2023010712

Ejemplares similares

Quantification of Neutrophil Extracellular Traps (NETs) in Pediatric Patients with COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) through Plasma and Peripheral Smear Analysis
por: Thompson, Rachelle, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-Cell Therapy Clinical Results in Pediatric and Young Adult B-ALL
por: DiNofia, Amanda M., et al.
Publicado: (2019)

Evidence of Microangiopathy in Children with Sars-Cov-2 Regardless of Clinical Presentation
por: Diorio, Caroline, et al.
Publicado: (2020)

Efficacy and safety of emapalumab in macrophage activation syndrome
por: De Benedetti, Fabrizio, et al.
Publicado: (2023)

Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL)
por: Merli, Pietro, et al.
Publicado: (2020)

Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States
por: DiNofia, Amanda M., et al.
Publicado: (2016)

Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations
por: Diorio, Caroline, et al.
Publicado: (2020)

The Role of PF4 Antibodies in Pediatric Sars-Cov-2 Infections
por: Chiem, Meady, et al.
Publicado: (2021)

Sars-Cov-2 Infections in CAR T Cell Recipients
por: McNerney, Kevin O., et al.
Publicado: (2021)

Skewed Cytokine Responses Rather Than the Magnitude of the Cytokine Storm May Drive Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children
por: Chang, Joyce C., et al.
Publicado: (2021)

Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model‐based approach
por: Jacqmin, Philippe, et al.
Publicado: (2021)

Successful use of emapalumab in refractory hemophagocytic lymphohistiocytosis in a child with Chédiak–Higashi syndrome: a case report
por: AlAhmari, Ali, et al.
Publicado: (2023)

Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase III high‐risk B acute lymphoblastic leukemia trial AALL0232
por: DiNofia, Amanda M., et al.
Publicado: (2017)

Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis- related graft failure and disseminated bacillus Calmette-Guérin infection
por: Tucci, Francesca, et al.
Publicado: (2020)

IL-1 receptor antagonist, MIS-C, and the peculiar autoimmunity of SARS-CoV-2
por: Bassiri, Hamid, et al.
Publicado: (2022)

Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction
por: Diorio, Caroline, et al.
Publicado: (2021)

Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors
por: Cure, Erkan, et al.
Publicado: (2021)

Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
por: Chellapandian, Deepak, et al.
Publicado: (2023)

Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies
por: Li, Yimei, et al.
Publicado: (2022)

Diagnostic Challenges in Pediatric Hemophagocytic Lymphohistiocytosis
por: Si, Stephanie J., et al.
Publicado: (2021)

Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
por: Hsieh, Emily M., et al.
Publicado: (2022)

A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies
por: Newman, Haley, et al.
Publicado: (2022)

Schuelke MR, Bassiri H, Behrens EM, et al. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood Adv. 2023;7(18):5603–5607.
Publicado: (2023)

Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL
por: Myers, Regina M., et al.
Publicado: (2022)

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
por: Lamble, Adam J., et al.
Publicado: (2022)

A unified approach for debugging is-a structure and mappings in networked taxonomies
por: Lambrix, Patrick, et al.
Publicado: (2013)

Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived States
por: Khurana, Priya, et al.
Publicado: (2021)

Monoclonal antibody 2C5 specifically targets neutrophil extracellular traps
por: Mendes, Livia P., et al.
Publicado: (2020)

A Narrative Literature Review of the Established Safety of Human Serum Albumin Use as a Stabilizer in Aesthetic Botulinum Toxin Formulations Compared to Alternatives
por: Sattler, Sonja, et al.
Publicado: (2023)

Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL
por: Diorio, Caroline, et al.
Publicado: (2022)

Completing the is-a structure in light-weight ontologies
por: Lambrix, Patrick, et al.
Publicado: (2015)

Neutrophil extracellular trap stabilization by platelet factor 4 reduces thrombogenicity and endothelial cell injury
por: Ngo, Anh T. P., et al.
Publicado: (2023)

The science of childhood and the pedagogy of the state: Postcolonial development in India, 1950s
por: Sriprakash, Arathi, et al.
Publicado: (2019)

CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition
por: Meyer, Lauren K., et al.
Publicado: (2019)

Knowledge engineering and knowledge management: 19th international conference, EKAW 2014, Linköping, Sweden, November 24-28, 2014, proceedings
por: Janowicz, Krzysztof, et al.
Publicado: (2014)

Experiences from the anatomy track in the ontology alignment evaluation initiative
por: Dragisic, Zlatan, et al.
Publicado: (2017)

SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19
por: Anderson, Elizabeth M., et al.
Publicado: (2020)

IL-10 is a critical negative regulator of macrophage activation syndrome
por: Canna, Scott, et al.
Publicado: (2012)

Autoimmune lymphoproliferative syndrome: more than a FAScinating disease
por: Bride, Karen, et al.
Publicado: (2017)

Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date
por: Si, Stephanie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oh3jo3a7kog9g3ks2g9h9gmff5